Gala Renee D Insider Trades & Stock Holdings

President & CEO · Jazz Pharmaceuticals plc · Latest filing Oct 6, 2026

Gala Renee D, President & CEO at Jazz Pharmaceuticals plc has 1 Form 4 trade on file since Oct 6, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($472.80K), net -$472.80K. Latest filing: disposed of 2K shares of $JAZZ on Oct 6, 2026 at $236.40.

Trades on file

1

Open-market bought

$0

Open-market sold

$472.80K

Net open-market

-$472.80K

Latest filing

Oct 6, 2026

All insider trades by Gala Renee D

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 6, 2026	$JAZZ	Sell (Open-market sale) 10b5-1	2K	$236.40	$472.80K			-9.1%			President & CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Gala Renee D traded

• $JAZZ

Frequently asked questions

Has Gala Renee D been buying or selling stock?

Gala Renee D has 0 open-market purchases and 1 open-market sale on file, net -$472.80K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Gala Renee D's latest insider trade?

disposed of 2K shares of $JAZZ on Oct 6, 2026 at $236.40.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.